AR036462A1 - Un compuesto esteroidal y su uso para la fabricacion de un medicamento - Google Patents
Un compuesto esteroidal y su uso para la fabricacion de un medicamentoInfo
- Publication number
- AR036462A1 AR036462A1 ARP020103415A ARP020103415A AR036462A1 AR 036462 A1 AR036462 A1 AR 036462A1 AR P020103415 A ARP020103415 A AR P020103415A AR P020103415 A ARP020103415 A AR P020103415A AR 036462 A1 AR036462 A1 AR 036462A1
- Authority
- AR
- Argentina
- Prior art keywords
- manufacture
- steroidal compound
- medicinal product
- compound
- alkyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 230000003637 steroidlike Effects 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 239000003098 androgen Substances 0.000 abstract 1
- 230000001548 androgenic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01203455 | 2001-09-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR036462A1 true AR036462A1 (es) | 2004-09-08 |
Family
ID=8180920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020103415A AR036462A1 (es) | 2001-09-12 | 2002-09-10 | Un compuesto esteroidal y su uso para la fabricacion de un medicamento |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7169769B2 (enExample) |
| EP (1) | EP1427748B1 (enExample) |
| JP (1) | JP4471653B2 (enExample) |
| KR (1) | KR100940054B1 (enExample) |
| CN (1) | CN1257913C (enExample) |
| AR (1) | AR036462A1 (enExample) |
| AT (1) | ATE395352T1 (enExample) |
| AU (1) | AU2002339536B2 (enExample) |
| BR (1) | BR0212409A (enExample) |
| CA (1) | CA2505575C (enExample) |
| CY (1) | CY1108152T1 (enExample) |
| DE (1) | DE60226623D1 (enExample) |
| DK (1) | DK1427748T3 (enExample) |
| EC (1) | ECSP045012A (enExample) |
| ES (1) | ES2305306T3 (enExample) |
| HR (1) | HRP20040193A2 (enExample) |
| HU (1) | HUP0402139A3 (enExample) |
| IL (2) | IL160451A0 (enExample) |
| IS (1) | IS2555B (enExample) |
| MX (1) | MXPA04002418A (enExample) |
| NO (1) | NO326624B1 (enExample) |
| NZ (1) | NZ531487A (enExample) |
| PL (1) | PL207493B1 (enExample) |
| PT (1) | PT1427748E (enExample) |
| RU (1) | RU2294332C2 (enExample) |
| TW (1) | TWI221154B (enExample) |
| WO (1) | WO2003022864A1 (enExample) |
| ZA (1) | ZA200401992B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI221154B (en) | 2001-09-12 | 2004-09-21 | Akzo Nobel Nv | 17alpha-hydroxy-14beta-steroids with hormonal effect |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3338925A (en) * | 1965-10-25 | 1967-08-29 | Syntex Corp | 17-substituted 14beta-estr-4-enes |
| WO2000053619A1 (en) * | 1999-03-08 | 2000-09-14 | Akzo Nobel N.V. | 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens |
| AU4299301A (en) * | 2000-02-29 | 2001-09-12 | National University Of Singapore, The | A method for modulating steroidogenic activity |
| US6391868B2 (en) * | 2000-05-10 | 2002-05-21 | Lpt Research, Inc. | Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans |
| TWI221154B (en) | 2001-09-12 | 2004-09-21 | Akzo Nobel Nv | 17alpha-hydroxy-14beta-steroids with hormonal effect |
-
2002
- 2002-07-19 TW TW091116164A patent/TWI221154B/zh not_active IP Right Cessation
- 2002-09-06 HR HR20040193A patent/HRP20040193A2/hr not_active Application Discontinuation
- 2002-09-06 JP JP2003526937A patent/JP4471653B2/ja not_active Expired - Fee Related
- 2002-09-06 CN CNB02817853XA patent/CN1257913C/zh not_active Expired - Lifetime
- 2002-09-06 NZ NZ531487A patent/NZ531487A/en not_active IP Right Cessation
- 2002-09-06 AT AT02777036T patent/ATE395352T1/de active
- 2002-09-06 EP EP02777036A patent/EP1427748B1/en not_active Expired - Lifetime
- 2002-09-06 IL IL16045102A patent/IL160451A0/xx unknown
- 2002-09-06 US US10/489,456 patent/US7169769B2/en not_active Expired - Lifetime
- 2002-09-06 PT PT02777036T patent/PT1427748E/pt unknown
- 2002-09-06 HU HU0402139A patent/HUP0402139A3/hu unknown
- 2002-09-06 DK DK02777036T patent/DK1427748T3/da active
- 2002-09-06 ES ES02777036T patent/ES2305306T3/es not_active Expired - Lifetime
- 2002-09-06 MX MXPA04002418A patent/MXPA04002418A/es active IP Right Grant
- 2002-09-06 PL PL368727A patent/PL207493B1/pl not_active IP Right Cessation
- 2002-09-06 RU RU2004110934/04A patent/RU2294332C2/ru not_active IP Right Cessation
- 2002-09-06 BR BR0212409-2A patent/BR0212409A/pt not_active IP Right Cessation
- 2002-09-06 AU AU2002339536A patent/AU2002339536B2/en not_active Expired
- 2002-09-06 KR KR1020047003609A patent/KR100940054B1/ko not_active Expired - Fee Related
- 2002-09-06 CA CA2505575A patent/CA2505575C/en not_active Expired - Lifetime
- 2002-09-06 DE DE60226623T patent/DE60226623D1/de not_active Expired - Lifetime
- 2002-09-06 WO PCT/EP2002/010041 patent/WO2003022864A1/en not_active Ceased
- 2002-09-10 AR ARP020103415A patent/AR036462A1/es unknown
-
2004
- 2004-02-18 IL IL160451A patent/IL160451A/en not_active IP Right Cessation
- 2004-02-26 IS IS7165A patent/IS2555B/is unknown
- 2004-03-10 EC EC2004005012A patent/ECSP045012A/es unknown
- 2004-03-10 NO NO20041010A patent/NO326624B1/no not_active IP Right Cessation
- 2004-03-11 ZA ZA200401992A patent/ZA200401992B/en unknown
-
2008
- 2008-06-19 CY CY20081100653T patent/CY1108152T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0104654A (pt) | Artigo absorvente | |
| AR030707A1 (es) | 9-ALFA-CLORO-6-ALFA-FLUOR-17-ALFA-HIDROXI-16-METIL-17-BETA-METOXICARBONIL-ANDROST-1,4-DIENOS, UN PROCESO PARA SU PREPARACIoN , COMPOSICION FARMACEUTICA, Y EL USO DEL MISMO PARA LA FABRICACION DE MEDICAMENTO | |
| AR063555A1 (es) | Derivados de androstano, su uso en la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden y procesos para prepararlos | |
| SI1534678T1 (sl) | Plevromutilinski derivati kot antimikrobna sredstva | |
| UY27437A1 (es) | Compuestos químicos | |
| MX9302214A (es) | Derivados de taxol y proceso para su preparacion | |
| AR077416A2 (es) | Compuesto polimorfo estable de flibanserina , procedimiento industrial para su preparacion y uso del mismo para preparar medicamentos | |
| NO20032805L (no) | Blandinger med ostrogen-syklodekstrinkomplekser | |
| BR9916772A (pt) | Quinolinacarboxamidas como agentes antivirais | |
| BR0107667A (pt) | Composto de linezolida em forma de cristal que e farmaceuticamente útil como agente antibacteriano e método de preparação do mesmo | |
| BRPI0400214A (pt) | Composições e aplicações farmacêuticas para a obtenção confiável de nìveis aceitáveis de testosterona no soro | |
| CO5631449A2 (es) | Nuevos esteres de etonogestrel | |
| HUP9902449A2 (hu) | Androsztén-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| AR025052A1 (es) | Derivados de 2-dialquilaminoalquilbifenilo sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estoscompuestos para la preparacion de medicamentos. | |
| ECSP055629A (es) | COMPOSICIÓN QUE CONTIENE UN ESTEROIDE 11ß-HALOGENADO ANDRÓGENO Y UN GESTÁGENO ASÍ COMO UN CONTRACEPTIVO MASCULINO SOBRE LA BASE DE ESTAS COMPOSICIONES | |
| CA2013599A1 (en) | Aryl-substituted rhodanine derivatives | |
| NO20023276L (no) | Fremgangsmåter fremstilling av betulinsyre | |
| AR036462A1 (es) | Un compuesto esteroidal y su uso para la fabricacion de un medicamento | |
| AU2001293707A1 (en) | Anti-inflammatory medicament | |
| CA2434187A1 (en) | Androgenic 7-substituted 11-halogenated steroids | |
| AR016522A1 (es) | Produccion de compuestos de avermectina | |
| UY27372A1 (es) | Derivados de bencimidazol 1-aril-2-n, s u o-sustituidos, su uso para la obtención de medicamentos y preparados farmacéuticos que contienen estos derivados | |
| NO20031444L (no) | 17<alfa>-fluoralkylsteroider, fremgangsmåte for fremstilling av disse, og farmasöytiske preparater som inneholder disse forbindelser | |
| AR022852A1 (es) | Nuevos androgenos | |
| PE20020752A1 (es) | Esteroides con doble enlace delta 14 sustituido en las posiciones 13 y 14 con actividad androgenica y progestagena |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |